|
1
|
Schmader KE: Epidemiology and impacton
quality of life of postherpetic neuralgiaand painful diabetic
neuropathy. Clin J Pain. 18:350–354. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bouhassira D, Lantéri-Minet M, Attal N,
Laurent B and Touboul C: Prevalence of chronic pain with
neuropathic characteristics in the general population. Pain.
136:380–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dworkin RH, O'Connor AB, Backonja M,
Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski
C, Nurmikko TJ, et al: Phgroupacologic management of neuropathic
pain: Evidence based recommendations. Pain. 132:237–251. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dworkin RH, O'Connor AB, Audette J, Baron
R, Gourlay GK, Haanpää ML, Kent JL, Krane EJ, Lebel AA, Levy RM, et
al: Recommendations for the pharmacological management of
neuropathic pain: an overview and literature update. Mayo Clin
Proc. 85:(Suppl 3). S3–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Attal N, Cruccu G, Haanpää M, Hansson P,
Jensen TS, Nurmikko T, Sampaio C, Sindrup S and Wiffen P: EFNS Task
Force: EFNS guidelineson phgroupacological treatment of neuropathic
pain. Eur J Neurol. 13:1153–1189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rosenstock J, Tuchman M, LaMoreaux L and
Shgroupa U: Pregabalin for the treatment of painful diabetic
peripheral neuropathy: A double-blind, placebo-controlled trial.
Pain. 110:628–638. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lesser H, Shgroupa U, LaMoreaux L and
Poole RM: Pregabalin relieves symptoms of painful diabetic
neuropathy: A randomized controlled trial. Neurology. 63:2104–2110.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Richter RW, Portenoy R, Shgroupa U,
Lamoreaux L, Bockbrader H and Knapp LE: Relief of painful diabetic
peripheral neuropathy with pregabalin: A randomized,
placebo-controlled trial. J Pain. 6:253–260. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Freynhagen R, Strojek K, Griesing T,
Whalen E and Balkenohl M: Efficacy of pregabalin inneuropathic pain
evaluated in a 12-week, randomized, double-blind, multicentre,
placebo-controlled trial of flexible- and fixed-dose regimens.
Pain. 115:254–263. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Farrar JT, Young JP Jr, LaMoreaux L, Werth
JL and Poole RM: Clinical importance of changes in chronic pain
intensity measured on an 11-point numerical pain rating scale.
Pain. 94:149–158. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rowbotham MC: What is a ‘clinically
meaningful’ reduction in pain? Pain. 94:131–132. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cleeland CS and Ryan KM: Pain assessment:
Global use of the Brief pain inventory. Ann Acad Med Singapore.
23:129–138. 1994.PubMed/NCBI
|
|
13
|
Bonezzi C, Nava A, Barbieri M, Bettaglio
R, Demartini L, Miotti D and Paulin L: Validazione della versione
italiana del Brief Pain inventory nei pazienti con dolore cronico.
Minerva Anestesiol. 68:607–611. 2002.(In Italian). PubMed/NCBI
|
|
14
|
Watson CP, Moulin D, Watt-Watson J, Gordon
A and Eisenhoffer J: Controlled-release oxycodone relieves
neuropathic pain: A randomized controlled trial in painful diabetic
neuropathy. Pain. 105:71–78. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eisenberg E, McNicol ED and Carr DB:
Efficacy and safety of opioid agonists in the treatment of
neuropathic pain of nonmalignant origin: Systematic review and
meta-analysis of randomized controlled trials. JAMA. 293:3043–3052.
2005. View Article : Google Scholar : PubMed/NCBI
|
